Total Payments
$6,063
2024 Payments
$505.30
Companies
17
Transactions
122
Medicare Patients
573
Medicare Billing
$42,730
Payment Breakdown by Category
Food & Beverage$3,063 (50.5%)
Consulting$3,000 (49.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,063 | 120 | 50.5% |
| Consulting Fee | $3,000 | 2 | 49.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $3,311 | 14 | $0 (2024) |
| ABBVIE INC. | $1,388 | 47 | $0 (2024) |
| PFIZER INC. | $300.89 | 11 | $0 (2024) |
| Celgene Corporation | $147.18 | 4 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $125.84 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $122.60 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $99.00 | 1 | $0 (2021) |
| GENZYME CORPORATION | $88.74 | 4 | $0 (2024) |
| Braintree Laboratories, Inc. | $83.91 | 5 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $82.88 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $505.30 | 16 | Janssen Biotech, Inc. ($164.46) |
| 2023 | $3,950 | 37 | Janssen Biotech, Inc. ($3,071) |
| 2022 | $965.54 | 38 | ABBVIE INC. ($536.59) |
| 2021 | $642.03 | 31 | AbbVie Inc. ($234.70) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: GI COLON PREP | ||||||
| 10/28/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $92.59 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $145.37 | General |
| Category: Immunology | ||||||
| 05/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.31 | General |
| Category: GI | ||||||
| 04/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Immunology | ||||||
| 03/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Immunology | ||||||
| 02/22/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Immunology | ||||||
| 02/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: GI | ||||||
| 02/15/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Immunology | ||||||
| 02/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Immunology | ||||||
| 12/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology | ||||||
| 11/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/27/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 10/21/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 10/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/11/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 142 | 145 | $26,420 | $10,187 |
| 2022 | 4 | 162 | 174 | $30,157 | $11,424 |
| 2021 | 4 | 145 | 160 | $26,049 | $11,749 |
| 2020 | 3 | 124 | 132 | $22,843 | $9,370 |
Total Patients
573
Total Services
611
Medicare Billing
$42,730
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 73 | $13,240 | $5,302 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,150 | $2,346 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 35 | $4,580 | $1,656 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,450 | $882.60 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 85 | $14,729 | $5,847 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 40 | $5,466 | $2,010 | 36.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $5,130 | $1,819 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,832 | $1,749 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 65 | $10,715 | $4,995 | 46.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $6,776 | $2,669 | 39.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 45 | $4,994 | $2,532 | 50.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $3,564 | $1,553 | 43.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 53 | 53 | $12,455 | $4,741 | 38.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 46 | $6,992 | $3,097 | 44.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 33 | $3,396 | $1,532 | 45.1% |
About Mary Yursky, CNP
Mary Yursky, CNP is a Gastroenterology healthcare provider based in North Ridgeville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144246570.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Yursky, CNP has received a total of $6,063 in payments from pharmaceutical and medical device companies, with $505.30 received in 2024. These payments were reported across 122 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,063).
As a Medicare-enrolled provider, Yursky has provided services to 573 Medicare beneficiaries, totaling 611 services with total Medicare billing of $42,730. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location North Ridgeville, OH
- Active Since 07/15/2006
- Last Updated 11/19/2020
- Taxonomy Code 163WG0100X
- Entity Type Individual
- NPI Number 1144246570
Products in Payments
- STELARA (Biological) $3,129
- RINVOQ (Biological) $680.11
- SKYRIZI (Biological) $392.04
- ZEPOSIA (Drug) $246.18
- XELJANZ (Drug) $208.30
- DUPIXENT (Biological) $153.72
- TREMFYA (Drug) $145.37
- HUMIRA (Biological) $126.76
- ENTYVIO (Biological) $125.84
- DIFICID (Drug) $122.60
- LINZESS (Drug) $92.69
- VELSIPITY (Drug) $92.59
- Linzess (Drug) $82.88
- MAVYRET (Drug) $74.34
- ZENPEP (Drug) $68.89
- SUTAB (Drug) $68.80
- XIFAXAN (Drug) $56.22
- SUCRAID (Drug) $54.74
- OMVOH (Drug) $40.46
- REMICADE (Biological) $36.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.